ANC

Feb 11 2026HEALTH

Real‑World Studies Outshine Single‑Arm Trials for Cancer Survival

Experts from European oncology societies and regulatory bodies compared different study designs to see which gives the strongest evidence that a new cancer drug truly improves survival. They used a method called conjoint analysis to score how convincing each study type was under various conditions,

reading time less than a minute
Feb 11 2026BUSINESS

Closing of Oakland’s Athletic Club: A Last Game

The Athletic Club in Oakland has closed its doors after eight years of serving fans and friends. The final day coincided with the Super Bowl, adding a bittersweet note to its farewell. A post on Instagram announced the closure and thanked patrons for their support. Co‑owner Miles Palliser expressed

reading time less than a minute
Feb 11 2026SPORTS

Balancing Fame, School and a Future: How One Skier Is Redefining Success

Eileen Gu has become a household name in the world of sports, not just because she excels on the slopes but also due to her savvy business moves. In 2023, Forbes reported that she earned $23. 1 million, placing her ahead of well‑known athletes like Naomi Osaka and Caitlin Clark. Her wealth comes lar

reading time less than a minute
Feb 11 2026SPORTS

'Wembley Could Be the Turning Point for Arsenal'

'Arsenal has reached the League Cup final again, a moment that feels like a fresh start after their last appearance in 2018. Back then, under Wenger, the team lost 3‑0 to Manchester City in a match that still feels painful. Now, with Arteta at the helm, the club has grown stronger over four seasons

reading time less than a minute
Feb 11 2026BUSINESS

Madrigal Secures Major Deal to Battle Liver Disease

A Chinese biotech company in Suzhou has given an American firm the worldwide rights to create and sell six new RNA medicines aimed at a serious liver condition. The deal brings an upfront cash payment of $60 million and could grow to nearly $4. 5 billion if the medicines reach several key develop

reading time less than a minute
Feb 11 2026HEALTH

Food Preservative BHA Under New Safety Review

The U. S. Food and Drug Administration has started a fresh examination of butylated hydroxyanisole, a preservative that keeps many packaged foods from spoiling. The agency wants the public to share any new data on how BHA is used and whether it remains safe. This effort follows a 2025 program

reading time less than a minute
Feb 11 2026FINANCE

Snowbird Dreams Shift: Why Retirees Are Renting Instead of Buying

The idea that retirees can swap snowy winters for sunny months in a second home has long been a dream. For decades, people from cold northern states and Canada would buy condos or houses in places like Florida, Arizona, and the Gulf Coast. They stayed there for three to six months each year, fueling

reading time less than a minute
Feb 11 2026BUSINESS

Ford Faces Record Loss as Electric Drive Stumbles

Ford’s latest earnings reveal the biggest quarterly hit in four years, with a net loss of $8. 2 billion for 2025 – the worst since the 2008 downturn. The blow comes largely from its electric vehicle (EV) arm, which posted a $4. 8 billion loss this year. Sales of EVs fell sharply after the U. S

reading time less than a minute
Feb 11 2026HEALTH

Social Media Use, Mood and Grades in Libyan Med Students

A recent survey looked at how often medical students in Libya use social media and whether that affects their mood or grades. The study used a standard questionnaire to measure “addiction” to social media, plus separate tools for depression and anxiety. It included students from their third ye

reading time less than a minute
Feb 11 2026HEALTH

Innovative Cancer Drug Faces Time‑Crunch in Cost Review

The latest study looks at how well a new drug, pemigatinib, works for patients with a rare liver cancer called intrahepatic cholangiocarcinoma. Researchers evaluated whether the drug’s benefits are worth its price compared to other treatments. The analysis starts by measuring how many months patien

reading time less than a minute